ReviewBJC reports2024

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit.

J B Schnog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.